细胞间粘附分子-1与自身免疫性甲状腺疾病
被引量：4
摘要
近年研究表明细胞间粘附分子 1与自身免疫性甲状腺疾病发病密切相关 ,综述了细胞间粘附分子 1的结构和功能、在自身免疫性甲状腺疾病中的表达、与甲状腺浸润淋巴细胞之间的相互作用、与甲状腺自身抗体之间的关系以及在甲状腺功能亢进伴突眼中的作用 ,并且简述了细胞间粘附分子 1的单克隆抗体的应用。
出处
《国外医学（内分泌学分册）》
2000年第4期175-178,共4页
Foreign Medical Sciences(Section of Endocrinology)
参考文献16
-
1WenischC,MyskiwD,GesslA,etal.Circulatingselectins,intercellularadhesionmolecule-1andvascularcelladhesionmolecule-1inhyperthyroidism[J].JClinEndocrinolMetab,1995,80:2122～2126.
-
2SchupperF,ReiserM,HeldinN-E,etal.Thyrotropinreceptorandleukocyteadhesionmoleculesinautoimmunethyroiddisease:astodyoftheirgeneexpressionbyNorthernblotanalysisandinsituhybridization[J].EurJEndocrinol,1994,131:480～488.
-
3MaraznelaM,PostigoAA,AcevesoA,etal.AdhesionmoleculesfromtheLFA-1/ICAM-1,3andVIA-4/VCAM-1pathwaysonTlymphocytesandvascularendotheliuminGraves′andHashimoto′sthyroidglands[J].JImmunol,1994,24:2483～2490.
-
4CagnescoM,PlesceGP,CarettoA,etal.FollicularthyroidcellsofautoimmunethyroiditismaycoexpressICAM-1(CD54)anditsnaturalligandLFA-1(CD1la/CD18)[J].JAllergyClinImmunol,1995,95:1036～1043.
-
5MatsuokaN,EguchiK,KawakamiA,etal.LackofB7-1/BB1andB7-2/B70expressiononthyrocytesofpatientswithGraves′disease.DeliveryofcostimulatorysignalsfromBystanderprofessionalantigen-presontingcells[J].JClinEndocrinolMetab,1996,81:4137～4143.
-
6AraoT,MorimotoI,KakinumaA,etal.Thyrocyteproliferationbycellularadhesiontoinfiltratinglymphocytesthroughtheintercellularadhesionmolecule-1/lymphocytefunction-associatedantigen-1pathwayinGraves′disease[J].JClinEndocrinolMetab,2000,85:382～389.
-
7HoemannR,SpitzwegC,PoertlS,etal.Regulationofintercellularadhesionmolecule-1expressioninhumanthyroidcellsinvitroandhumanthyroidtissuetransplantedtothenudemouseinvivo:thyrotropinreceptor[J].JClinEndocrinolMetab,1997,82:2048～2055.
-
8WenischC,MysliwD,ParschalkB,etal.Circulatingselectins,intercellularadhesionmolecule-1andvascularcelladhesionmolecule-1inhyperthyroidism[J].ClinExpImmunol,1994,98:240～244.
-
9MassartC,SonnetE,GibassierJ,etal.Clinicalvalidityofintercellularadhesionmolecule-1(ICAM-I)andTSHreceporantibodiesinserafrompatientswithGraves′disease[J].ClinChimActa,1997,265:157～168.
-
10SonnetE,MassartC,GibassierJ,etal.Expressionofmembraneandsolubleintercellularadhesionmolecule-1inGraves′disesse[J].JEndocrinolInvest,1999,22:430～435.
同被引文献34
-
1高天舒,李静,滕卫平.中、轻度碘过量对大鼠甲状腺滤泡上皮凋亡及Fas/FasL表达的影响[J].中国地方病学杂志,2005,24(3):267-270. 被引量：11
-
2胡天一,刘戈力.趋化因子CXCL10及其受体CXCR3与Graves病[J].天津医科大学学报,2010,16(4):693-696. 被引量：1
-
3滕晓春,滕卫平.碘过量与甲状腺疾病[J].实用医院临床杂志,2007,4(5):5-7. 被引量：44
-
4Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature, 2001, 409(6818): 307-312.
-
5Patel SD, Rajala MW, Rossetti L, et al. Disulfide-dependent muhimeric assembly of resistin family hormones. Science, 2004, 304 (5674): 1154-1158.
-
6Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator - activated receptorgamma action in humans. Diabetes, 2001, 50(10): 2199-2202.
-
7Nagaev I, Smith U. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem Biophys Res Commun, 2001, 285(2): 561-564.
-
8Patel L, Buckels AC, Kinghorn IJ, et al. Resistin is expressed in human macrephages and directly regulated by PPAR gamma activators. Bioehem Biophys Res Commun, 2003, 300(2): 472-476.
-
9Nogueiras R, Gallego R, Gualillo O, et al. Resistin is expressed in different rat tissues and is regulated in a tissue and gender specific manner. FEBS Lett, 2003, 548(1-3): 21-27.
-
10Minn AH, Patterson NB, Pack S, et al. Resistin is expressed in pancreatic islets. Biochem Biophys Res Commun, 2003, 310 (2): 641-645.
引证文献4
-
1陈仲,韩佩珍.抵抗素研究进展及其在肿瘤核医学中的应用[J].国际放射医学核医学杂志,2007,31(3):138-140.
-
2曹晓晓,徐菁,王海燕,马巍,李秀维,王建强.碘过量对NOD·H-2^h4小鼠甲状腺转录组影响的分析[J].中国食物与营养,2020,26(5):75-79. 被引量：2
-
3李亚楠,孟献亚,沈洪婷,陈勋,马静,王明君,甘培春,姜泓,何多龙,喇翠玲,胡兰盛,周昕,曹晓晓.基于RNA-seq技术的碘过量对小鼠甲状腺转录组学影响的研究[J].中国地方病防治,2020,35(4):401-405. 被引量：1
-
4李亚楠,沈洪婷,王明君,陈勋,马静,甘培春,张强,张金梅,曹晓晓,孟献亚.过量碘通过p38和细胞间黏附分子-1促进小鼠实验性自身免疫性甲状腺炎的发生发展[J].中华地方病学杂志,2022,41(4):270-276.
二级引证文献2
-
1李亚楠,沈洪婷,王明君,陈勋,马静,甘培春,张强,张金梅,曹晓晓,孟献亚.过量碘通过p38和细胞间黏附分子-1促进小鼠实验性自身免疫性甲状腺炎的发生发展[J].中华地方病学杂志,2022,41(4):270-276.
-
2李佩花,王丽,赵乃倩.微量元素诱导桥本甲状腺炎发生发展的研究进展[J].新医学,2023,54(5):307-311. 被引量：2
-
1苏敏,牛恕淼.产后甲状腺炎—甲状腺浸润单个核细胞亚群原位免...[J].中国实验临床免疫学杂志,1991,3(5):17-19.
-
2李健,高慧,苏敏.自身免疫性甲状腺病甲状腺浸润细胞亚群的观察[J].中华内分泌代谢杂志,1994,10(2):92-93. 被引量：3
-
3王加林,赵亚平,范智勇,吴和军,周玮,刘泽红.Graves病患者甲状腺组织中凋亡蛋白Fas、FasL、Bcl-2和Bax的表达[J].中华内分泌代谢杂志,2003,19(2):92-94. 被引量：10
-
4杨慧英,傅祖植,孙朝昆.IL—2,IL—2R,IL—6mRNA在自身免疫性甲状腺病甲状腺组织中的原位表达[J].云南医药,2000,21(5):373-374. 被引量：1
-
5苏敏,牛恕淼,田东萍,李恒力,李健.地方性甲状腺肿甲状腺浸润细胞及滤泡上皮DR抗原表达免疫组化研究[J].地方病通报,1993,8(4):1-4.
-
6刘冬云.CMV-hFasL转基因小鼠能阻止实验性自身免疫性甲状腺炎的发病[J].中华医学信息导报,2005,20(11):9-9.
-
7孟凤苓,南国珍,苏胜偶,黄振国,张力辉,赵志弘.Graves病患者血清sICAM1水平的变化[J].基础医学与临床,2002,22(2):191-192.
